Ion Beam Applications (OTCMKTS:IOBCF) Shares Up 9.4% – What’s Next?

Ion Beam Applications SA (OTCMKTS:IOBCFGet Free Report) shares shot up 9.4% during mid-day trading on Friday . The company traded as high as $14.50 and last traded at $14.50. 350 shares traded hands during mid-day trading, a decline of 42% from the average session volume of 604 shares. The stock had previously closed at $13.25.

Ion Beam Applications Stock Up 9.4%

The firm’s fifty day simple moving average is $14.10 and its two-hundred day simple moving average is $13.74.

About Ion Beam Applications

(Get Free Report)

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.

Recommended Stories

Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.